Cleared Traditional

K092138 - JTS EXTENDEABLE IMPLANT

K092138 is the FDA 510(k) clearance for JTS EXTENDEABLE IMPLANT by Stanmore Implants Worldwide , Ltd.. It is a Class 2 Orthopedic device (product code KRO) cleared through the Traditional 510(k) pathway after a 615-day FDA review.

K092138 · Stanmore Implants Worldwide , Ltd. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2011
Decision
615d
Days
Class 2
Risk

K092138 is an FDA 510(k) clearance for the JTS EXTENDEABLE IMPLANT. Classified as Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/polymer (product code KRO), Class II - Special Controls.

Submitted by Stanmore Implants Worldwide , Ltd. (Washington, US). The FDA issued a Cleared decision on March 22, 2011 after a review of 615 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3510 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Orthopedic submissions.

View all Stanmore Implants Worldwide , Ltd. devices

Submission Details

510(k) Number K092138 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 2009
Decision Date March 22, 2011
Days to Decision 615 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
493d slower than avg
Panel avg: 122d · This submission: 615d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code KRO Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/polymer
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - KRO Prosthesis, Knee, Femorotibial, Constrained, Cemented, Metal/polymer

All 69
Devices cleared under the same product code (KRO) and FDA review panel - the closest regulatory comparables to K092138.
GMK HINGE
K130299 · Medacta International · Aug 2013
DISTAL FEMORAL GROWING PROSTHESIS, TIBIAL ROTATING COMPONENTS, BEARING, AXIS, CIRCLIP, WEDGE
K122015 · Howmedica Osteonics Corp. · Feb 2013
ZIMMER SEGMENT SYSTEM TRABECULAR METAL PROXIMAL TIBIAL COMPONENT, TRABECULAR METAL PROXIMAL COMPONENT, ADDITIONAL SEGMEN
K110940 · Zimmer, Inc. · Jul 2011
LPS UNIVERSAL TIBIAL HINGE INSERTS, MODEL 198727012-198727331
K091453 · DePuy Orthopaedics, Inc. · Aug 2009
MAK OSS KNEE FEMORAL COMPONENTS
K083779 · Biomet Manufacturing Corp · Apr 2009
ORTHOPEDIC SALVAGE SYSTEM (OSS) 9CM COBALT - CHROME TIBIAL BODIES
K083827 · Biomet Manufacturing Corp · Feb 2009